Los resultados se publicarán después del cierre del 28 de octubre de 2026. Las acciones de Teladoc Health registraron 606,93 millones de dólares.

Q3 results are scheduled for October 28, 2026 after the close. Teladoc Health stock is at EUR 5.13,

Revenue fell 4.00 percent year over year to USD 606.93 million. Teladoc Health stock enters the Octo

¿Qué accionistas están comprando/vendiendo acciones de Teladoc Health (NYSE:TDOC)? Vea las transacciones de propiedad institucional del TDOC (13F) en MarketBeat.

$50,000 of TELADOC HEALTH INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Discl

Second-quarter revenue fell 4.00 percent to USD 606.90 million in 2026. Teladoc Health stock costs E

NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2026 results on...

NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2026 results on Wednesday, October 28, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 833-461-5787 for U.S. participants and using the meeting ID # 404 870 451. For international p

In early October 2026, Teladoc Health announced two new AI-powered tools, SoloVitals and SoloScribe, embedding contactless vital-sign monitoring and ambient documentation directly into its Solo enterprise virtual care platform for hospitals and health systems. By integrating these AI capabilities into one platform instead of separate point solutions, Teladoc is aiming to simplify hospital technology stacks while keeping clinicians focused on patient care rather than administrative...

Detailed price information for Genedx Holdings Corp (WGS-Q) from The Globe and Mail including charting and trades.